STAAR Surgical Company
US ˙ NasdaqGM ˙ US8523123052

Introduction

This page provides a comprehensive analysis of the known insider trading history of Mark B Logan. Insiders are officers, directors, or significant investors in a company. It is illegal for insiders to make trades in their companies based on specific, non-public information. This does not mean it is illegal for them to make any trades in their own companies. However, they must report all trades to the SEC via a Form 4. Despite these restrictions, academic research suggests that insiders - in general - tend to outperform the market in their own companies.

Average Trade Profitability

The average trade profitability is the average return of all the open market purchases made by the insider in the last three years. To calculate this, we examine every open-market, unplanned purchase made by the insider, excluding all trades that were marked as part of a 10b5-1 trading plan. We then calculate the average performance of those trades over 3, 6, and 12 months, averaging each of those durations to generate a final performance metric for each trade. Finally, we average all of the performance metrics to calculate a performance metric for the insider. This list only includes insiders that have made at least three trades in the last two years.

If this insiders trade profitability is "N/A", then the insider either has not made any open-market purchases in the last three years, or the trades they’ve made are too recent to calculate a reliable performance metric.

Update Frequency: Daily

See the list of most profitable insider traders.

Companies with Reported Insider Positions

The SEC filings indicate Mark B Logan has reported holdings or trades in the following companies:

Security Title Latest Reported Holdings
US:STAA / STAAR Surgical Company Director 46,696
US:928551AA8 / VIVUS, Inc. Bond Director 25,000
How to Interpret the Charts

The following charts show the stock performance of securities subsequent to each open-market, non-planned trade made by Mark B Logan. Non-planned trade are trades that were not made as part of a 10b5-1 trading plan. The stock performance is charted as cumulative percent change in share price. For example, if an insider trade was made on January 1, 2019, the chart will show the daily percent change of the security to the present day. If the share price were to go from $10 to $15 during this time, the cumulative percent change in share price would be 50%. A change in price from $10 to $20 would be 100%, and a change in price of $10 to $5 would be -50%.

Ultimately, we are trying to determine how closely the insider’s trades correlate to excess returns (positive or negative) in the share price in order to see if the insider is timing their trades to profit from insider information. Consider the situation where an insider was doing this. In this situation, we would expect either (a) positive returns after purchases, or (b) negative returns after sales. In the case of (a), the PURCHASE chart would show a series of upwardly sloping curves, indicating positive returns after each purchase transaction. In the case of (b), the SALE chart would show a series of downward sloping curves, indicating negative returns after each sale transaction.

However, this alone is not enough to draw conclusions. If, for example, the share price of the company was in a non-cyclical climb over many years, then we would expect all the post-purchase plots to be upwardly sloping. Likewise, non-cyclical declines over many years would result in downward sloping post-trade plots. Neither of these charts would suggest insider trading activity.

The strongest indicator would be a situation where the share price was extremely cyclical, and there were both positive signals in the PURCHASE chart and negative plots on the SALE chart. This situation would be highly suggestive of an insider that was timing trades to their financial advantage.

Insider Purchases STAA / STAAR Surgical Company - Short Term Profit Analysis

In this section, we analyze the profitability of every unplanned, open-market insider purchase made in STAA / STAAR Surgical Company. This analysis helps to understand if the insider consistently generates abnormal returns, and is worth following. This analysis is for one-year following each trade, and the results are theoretical.

The following table shows the most recent open market purchases that were not part of an automatic trading plan.

Trade Date Ticker Insider Reported
Shares
Reported
Price
Adjusted
Shares
Adjusted
Price
Cost Basis Days to
Max
Price at
Max
Max
Profit ($)
Max Return (%)
2012-11-15 STAA LOGAN MARK B 600 5.0000 600 5.0000 3,000 348 13.7400 5,244 174.80
2012-11-08 STAA LOGAN MARK B 3,000 5.2693 3,000 5.2693 15,808
2012-05-31 STAA LOGAN MARK B 2,000 8.5500 2,000 8.5500 17,100
2012-05-23 STAA LOGAN MARK B 3,000 8.7500 3,000 8.7500 26,250

Adjusted Price is the split-adjusted price. Adjusted Shares is the split-adjusted shares.

STAA / STAAR Surgical Company Insider Trades
Insider Sales STAA / STAAR Surgical Company - Short Term Loss Analysis

In this section, we analyze the short-term loss avoidance of every unplanned, open-market insider sale made in STAA / STAAR Surgical Company. A consistent pattern of loss avoidance may suggest that future sale transactions may predict declines in price. This analysis is for one-year following each trade, and the results are theoretical.

The following table shows the most recent open market sales that were not part of an automatic trading plan.

Trade Date Ticker Insider Reported
Shares
Reported
Price
Adjusted
Shares
Adjusted
Price
Cost Basis Days to
Min
Price at
Min
Max Loss
Avoided ($)
Max Loss
Avoided (%)
There are no known unplanned open-market trades for this insider and security combination

Adjusted Price is the split-adjusted price. Adjusted Shares is the split-adjusted shares.

STAA / STAAR Surgical Company Insider Trades
Insider Trading History

This table shows the complete list of insider trades made by Mark B Logan as disclosed to the Securities Exchange Commission (SEC).

File Date Tran Date Form Ticker Security Code 10b5-1 Shares Remaining Shares Percent
Change
Share
Price
Tran
Value
Remaining
Value
2015-07-10 2015-07-08 4 STAA STAAR SURGICAL CO
Common Stock
A - Award 9,796 46,696 26.55
2014-06-11 2014-06-09 4 STAA STAAR SURGICAL CO
Common Stock Options
A - Award 10,000 10,000
2014-06-11 2014-06-09 4 STAA STAAR SURGICAL CO
Common Stock
A - Award 4,500 36,900 13.89
2013-08-16 2013-08-14 4 VVUS VIVUS INC
Non-Qualified Stock Option (right to buy)
A - Award 25,000 25,000
2013-05-14 2013-05-13 4 STAA STAAR SURGICAL CO
Common Stock
A - Award 10,800 32,400 50.00
2013-01-29 2013-01-25 4 VVUS VIVUS INC
Common Stock
A - Award 21,125 74,125 39.86
2012-11-16 2012-11-15 4 STAA STAAR SURGICAL CO
Common Stock
P - Purchase 600 19,600 3.16 5.00 3,000 98,000
2012-11-16 2012-11-08 4 STAA STAAR SURGICAL CO
Common Stock
P - Purchase 3,000 19,000 18.75 5.27 15,808 100,117
2012-08-15 2012-08-14 4 VVUS VIVUS INC
Non-Qualified Stock Option (right to buy)
M - Exercise -8,000 0 -100.00
2012-08-15 2012-08-14 4 VVUS VIVUS INC
Non-Qualified Stock Option (right to buy)
M - Exercise -8,000 0 -100.00
2012-08-15 2012-08-14 4 VVUS VIVUS INC
Non-Qualified Stock Option (right to buy)
M - Exercise -22,000 0 -100.00
2012-08-15 2012-08-14 4 VVUS VIVUS INC
Non-Qualified Stock Option (right to buy)
M - Exercise -11,816 0 -100.00
2012-08-15 2012-08-14 4 VVUS VIVUS INC
Common Stock
S - Sale -8,000 53,000 -13.11 23.13 -185,028 1,225,810
2012-08-15 2012-08-14 4 VVUS VIVUS INC
Common Stock
S - Sale -8,000 53,000 -13.11 23.13 -185,028 1,225,810
2012-08-15 2012-08-14 4 VVUS VIVUS INC
Common Stock
M - Exercise 8,000 61,000 15.09 7.15 57,200 436,150
2012-08-15 2012-08-14 4 VVUS VIVUS INC
Common Stock
S - Sale -22,000 53,000 -29.33 23.13 -508,827 1,225,810
2012-08-15 2012-08-14 4 VVUS VIVUS INC
Common Stock
M - Exercise 22,000 75,000 41.51 6.05 133,100 453,750
2012-08-15 2012-08-14 4 VVUS VIVUS INC
Common Stock
M - Exercise 8,000 61,000 15.09 5.04 40,320 307,440
2012-08-15 2012-08-14 4 VVUS VIVUS INC
Common Stock
S - Sale -11,816 53,000 -18.23 23.13 -273,286 1,225,810
2012-08-15 2012-08-14 4 VVUS VIVUS INC
Common Stock
M - Exercise 11,816 64,816 22.29 4.25 50,218 275,468
2012-08-14 2012-08-13 4 VVUS VIVUS INC
Non-Qualified Stock Option (right to buy)
M - Exercise -18,184 11,816 -60.61
2012-08-14 2012-08-13 4 VVUS VIVUS INC
Common Stock
S - Sale -18,184 53,000 -25.55 21.81 -396,580 1,155,893
2012-08-14 2012-08-13 4 VVUS VIVUS INC
Common Stock
M - Exercise 18,184 71,184 34.31 4.25 77,282 302,532
2012-06-19 2012-06-15 4 VVUS VIVUS INC
Common Stock
A - Award 5,000 53,000 10.42
2012-06-05 2012-05-31 4/A STAA STAAR SURGICAL CO
Common Stock
P - Purchase 2,000 15,000 15.38 8.55 17,100 128,250
2012-06-05 2012-05-23 4/A STAA STAAR SURGICAL CO
Common Stock
P - Purchase 3,000 16,000 23.08 8.75 26,250 140,000
2012-06-01 2012-05-31 4 STAA STAAR SURGICAL CO
Common Stock
A - Award 2,000 15,000 15.38 8.55 17,100 128,250
2012-05-24 2012-05-23 4 STAA STAAR SURGICAL CO
Common Stock
A - Award 3,000 16,000 23.08 8.75 26,250 140,000
2012-05-15 2012-05-14 4 STAA STAAR SURGICAL CO
Common Stock Options
A - Award 15,000 15,000
2012-05-15 2012-05-14 4 STAA STAAR SURGICAL CO
Common Stock
A - Award 3,000 13,000 30.00
2012-03-20 2012-03-16 4 VVUS VIVUS INC
Non-Qualified Stock Option (right to buy)
M - Exercise -4,000 0 -100.00
2012-03-20 2012-03-16 4 VVUS VIVUS INC
Non-Qualified Stock Option (right to buy)
M - Exercise -2,000 0 -100.00
2012-03-20 2012-03-16 4 VVUS VIVUS INC
Non-Qualified Stock Option (right to buy)
M - Exercise -8,000 0 -100.00
2012-03-20 2012-03-16 4 VVUS VIVUS INC
Common Stock
S - Sale -8,000 48,000 -14.29 20.32 -162,545 975,269
2012-03-20 2012-03-16 4 VVUS VIVUS INC
Common Stock
M - Exercise 8,000 56,000 16.67 3.90 31,200 218,400
2012-03-20 2012-03-16 4 VVUS VIVUS INC
Common Stock
S - Sale -4,000 48,000 -7.69 20.32 -81,272 975,269
2012-03-20 2012-03-16 4 VVUS VIVUS INC
Common Stock
M - Exercise 4,000 52,000 8.33 3.27 13,080 170,040
2012-03-20 2012-03-16 4 VVUS VIVUS INC
Common Stock
S - Sale -2,000 48,000 -4.00 20.32 -40,636 975,269
2012-03-20 2012-03-16 4 VVUS VIVUS INC
Common Stock
M - Exercise 2,000 50,000 4.17 3.13 6,260 156,500
2012-01-31 2012-01-27 4 VVUS VIVUS INC
Non-Qualified Stock Option (right to buy)
A - Award 25,000 25,000
2010-11-17 3 STAA STAAR SURGICAL CO
Common Stock
10,000
P
Open market or private purchase of non-derivative or derivative security
S
Open market or private sale of non-derivative or derivative security
A
Grant, award, or other acquisition of securities from the company (such as an option)
C
Conversion of derivative
D
Sale or transfer of securities back to the company
F
Payment of exercise price or tax liability using portion of securities received from the company
G
Gift of securities by or to the insider
K
Equity swaps and similar hedging transactions
M
Exercise or conversion of derivative security received from the company (such as an option)
V
A transaction voluntarily reported on Form 4
J
Other (accompanied by a footnote describing the transaction)